Seegene, Springer Nature Open 2025–26 MDx Grant Applications
The program focuses on antibiotic resistance in urinary tract infections (UTI-DR), with applications open until November...
Valo Health Awarded Grant to Advance Parkinson’s Disease Research
Valo to leverage human causal biology expertise to uncover new insights about NOD2 as a...
Vyome Holdings Adds Industry Veterans as It Plans Pivotal Trial Studies
Dr. Richard Fahrner and Dr. Tamara Agajanov add expertise in accelerated approvals Vyome Holdings, Inc....
Precision BioSciences Secures U.S. Patent for PBGENE-HBV
Strengthens the Company’s intellectual property portfolio for lead in vivo program PBGENE-HBV with U.S. patent...
Regeneron Reports Positive Phase 3 Data for Allergy Antibodies
In separate cat and birch allergen-challenge trials, single doses of allergen-specific antibody blockers significantly reduced...
IDEAYA Reports Positive Phase 2 Data for Darovasertib in UM
IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, will present positive interim data...